Olinger Margaret 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 20, 2023
Insider Transaction Report
Form 4
Olinger Margaret
Chief Commercial Officer
Transactions
- Award
Common Stock
2023-03-16+18,333→ 232,688 total - Award
Stock Option (right to buy)
2023-03-16+82,500→ 82,500 totalExercise: $32.08Exp: 2033-03-16→ Common Stock (82,500 underlying)
Footnotes (2)
- [F1]The reported transaction involves the Reporting Person's receipt of a restricted stock unit award (a "RSU"). The RSU shall vest in 4 equal annual installments, with the first installment vesting on the first day of the month of the one year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
- [F2]1/4 of the shares subject to the option shall vest and become exercisable on the first day of the month of the one year anniversary of the date of grant, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through such vesting date.